openPR Logo
Press release

Narcolepsy Therapeutics Market Overview with Size & Forecast during 2018 – 2025 | Arena Pharmaceuticals Inc., Cephalon Inc., Evotec, Graymark Healthcare Inc., Hypnion Inc.

11-21-2018 03:16 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Narcolepsy Therapeutics Market

Narcolepsy Therapeutics Market

Narcolepsy is a therapeutic disorder which is categorized by prodigious daytime sleepiness as well as sudden attacks of sleep. In some cases, this chronic sleep disease can lead to an abrupt loss of muscle tone (cataplexy), leading to loss and weakness of muscle control. Some of the most common indications of narcolepsy are daytime sleepiness, hallucinations, fragmented sleep & insomnia, and sleep paralysis.

The Global Narcolepsy Therapeutics Market is anticipated to reach over USD 3263.65 Million by 2025 according to a new research published by Polaris Market Research.

Rising disposable income, increasing investments in biotechnology and pharmaceutical sectors, economic development, supportive government initiatives, and rising awareness among people regarding the appropriate therapies are the factors expected to significantly boost the market in the Asia Pacific.

For more Professional and Technical Insights Request Sample @
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/request-for-free-sample

Growing incidence of narcolepsy and increasing overweight populace are the major factors estimated to drive the global narcolepsy therapeutics market growth. For instance, according to the Sleep Science journal 2017 report, it was estimated that around 1 in every 2,000 people across the globe are suffering from narcolepsy disorder.

Moreover, according to the Australian Institute of Health and Welfare, around 63% of the Australian individuals who are aged over 18 years were estimated to be obese or overweight. Additionally, growing research and development activities and growing demands for effective treatment of the disease are other factors expected to boost the market growth.

However, low per capita healthcare spending and lack of awareness majorly in middle income and lower-income economies is estimated to hinder the market during the forecast period.

Some major key players in global Narcolepsy Therapeutics Market include: -
• Addrenex Pharmaceuticals Inc.
• Arena Pharmaceuticals Inc.
• BIOPROJET
• Cephalon Inc.
• Evotec AG
• Graymark Healthcare Inc.
• Hypnion Inc.
• Jazz Pharmaceuticals Inc.
• Ligand Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd

Make an Enquiry for 'Queries' related to this research report @
https://www.polarismarketresearch.com/industry-analysis/global-narcolepsy-therapeutics-market/inquire-before-buying

Narcolepsy Therapeutics Market is segmented on the basis of product, type, and geography.

On the basis of product, the market is segmented into Sodium Oxybate, Central Nervous System Stimulants, Selective Serotonin Reuptake Inhibitor, and Tricyclic Antidepressants. In 2017, Sodium oxybate was estimated to domkiat5e the market segment. The dominance is due to the presence of favorable reimbursement guidelines, the high cost of this drug, and the increasing awareness levels relating to diagnosis & associated treatments of the disease.

On the basis of type, the market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. In 2017, the Narcolepsy with cataplexy segment was estimated to dominate the market growth. The dominance is attributed to the growing incidence of cataplexy as a major indication in patients.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Europe was estimated to dominate the Narcolepsy Therapeutics Market. The dominance is majorly attributed to the well-established healthcare organizations, rising R&D initiatives for the expansion of novel drugs, and high incidence of people suffering from such disorder. However, Asia Pacific is expected to dominate the global Market during the forecast.

Partial TOC of Narcolepsy Therapeutics Market: -
1. Industry snapshot
2. Ecosystem analysis
3. Market Dynamics
4. Industry analysis - Porter's five force
5. Degree of competition
6. Market PEST Analysis
7. Market Value Chain Analysis
8. Industry Trends
9. Competitive Ranking Analysis

About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research and Consulting
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Narcolepsy Therapeutics Market Overview with Size & Forecast during 2018 – 2025 | Arena Pharmaceuticals Inc., Cephalon Inc., Evotec, Graymark Healthcare Inc., Hypnion Inc. here

News-ID: 1389740 • Views:

More Releases from Polaris Market Research & Consulting

Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR of 7.70% | Polaris Market Research
Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR …
𝑻𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝑪𝒐𝒐𝒍𝒊𝒏𝒈 𝑭𝒂𝒃𝒓𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝒘𝒂𝒔 𝒆𝒔𝒕𝒆𝒆𝒎𝒆𝒅 𝒂𝒕 𝑼𝑺𝑫 2.42 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2023. 𝑳𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅, 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒂𝒏𝒕𝒊𝒄𝒊𝒑𝒂𝒕𝒆𝒅 𝒕𝒐 𝒈𝒓𝒐𝒘 𝒕𝒐 𝑼𝑺𝑫 4.66 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2032, 𝒆𝒙𝒉𝒊𝒃𝒊𝒕𝒊𝒏𝒈 𝒂 𝒄𝒐𝒎𝒑𝒐𝒖𝒏𝒅 𝒂𝒏𝒏𝒖𝒂𝒍 𝒈𝒓𝒐𝒘𝒕𝒉 𝒓𝒂𝒕𝒆 (𝑪𝑨𝑮𝑹) 𝒐𝒇 7.70% 𝒐𝒗𝒆𝒓 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 𝒇𝒓𝒐𝒎 2024 𝒕𝒐 2032. 𝑻𝒉𝒆 𝒎𝒂𝒊𝒏 𝒇𝒂𝒄𝒕𝒐𝒓𝒔 𝒅𝒓𝒊𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒈𝒓𝒐𝒘𝒕𝒉 𝒂𝒓𝒆 𝒓𝒊𝒔𝒊𝒏𝒈 𝒅𝒊𝒔𝒑𝒐𝒔𝒂𝒃𝒍𝒆 𝒊𝒏𝒄𝒐𝒎𝒆 𝒂𝒏𝒅 𝒑𝒆𝒓 𝒄𝒂𝒑𝒊𝒕𝒂 𝒔𝒑𝒆𝒏𝒅𝒊𝒏𝒈, 𝒂𝒔 𝒘𝒆𝒍𝒍 𝒂𝒔 𝒂 𝒓𝒊𝒔𝒆 𝒊𝒏 𝒕𝒉𝒆 𝒅𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝒔𝒑𝒐𝒓𝒕𝒔 𝒂𝒏𝒅
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2032 |according to a new study by Polaris Market Research
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2 …
The global Connected Medical Devices Market was valued at USD 49.57 billion in 2022. Looking forward, the market is projected to grow to USD 190.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% over the forecast period from 2023 to 2032. The rising aging population and the expansion of telehealth services are the primary factors propelling the market forward. Besides, the growing prevalence of chronic diseases
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by Polaris Market Research
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by …
According to a new market research report published by Polaris Market Research, the global Surgical Blade Market is expected to grow at a CAGR of 5.0% from 2023 to 2032. Its examination of technological progressions and developments in the industry and their influence on market attendance is anticipated to drive market expansion. The global market was valued at USD 140.59 million in 2022 to USD 228.57 million by 2032, disclosing
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion By 2032
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion …
𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 Continuing research into the health benefits of FOS and inventive commodity advancement has the possibility of capitulating new FOS-dependent commodities with improved functionality, which is pushing the market growth. Our thorough analysis of the Fructooligosaccharides Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments. 𝐓𝐡𝐞 𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 • Market Size: The global market for fructooligosaccharides was valued

All 5 Releases


More Releases for Narcolepsy

Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques. To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068 Moreover, constant development of
A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Market Trends, outlook and Opportunity Analysis 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime